Oxelumab is a human monoclonal antibody targeting human OX40L. OX40L is the ligand of OX40, which is expressed on activated T cells, natural killer (NK) cells and natural killer T (NKT) cells.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.